Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 51 | 0 | 7 | 0 | 732,70 € | 766,92 € | 4,67 % |
| Biogen Inc. | 44 | 2 | 4 | 1 | 201,40 € | 293,57 € | 45,77 % |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | 368,10 € | 382,71 € | 3,97 % |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 7 | 1 | 834,80 € | 957,22 € | 14,66 % |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | 121,00 € | 124,93 € | 3,25 % |
| Amgen Inc. | 21 | 0 | 3 | 0 | 256,75 € | 294,28 € | 14,62 % |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | 75,66 € | 102,62 € | 35,63 % |
| Zoetis Inc. A | 21 | 1 | 4 | 1 | 149,32 € | 200,06 € | 33,98 % |
| AbbVie Inc. | 20 | 1 | 3 | 1 | 152,38 € | 174,43 € | 14,47 % |
| Novo Nordisk A/S ADR | 17 | 1 | 2 | 0 | 120,50 € | 130,44 € | 8,25 % |
| Abbott Laboratories | 16 | 0 | 4 | 0 | 99,29 € | 116,81 € | 17,64 % |
| Bayer AG | 15 | 1 | 0 | 0 | 27,32 € | 50,00 € | 83,05 % |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | 61,08 € | 86,77 € | 42,06 % |
| Teva Pharmaceutical Industries Ltd ADR | 11 | 0 | 0 | 0 | 13,20 € | 13,68 € | 3,64 % |
| Sanofi S.A. ADR | 11 | 0 | 0 | 0 | 45,80 € | - | - |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | 185,00 € | 182,50 € | -1,35 % |
| GSK plc ADR | 4 | 0 | 0 | 0 | 38,20 € | 35,00 € | -8,38 % |
| Sanofi S.A. | 4 | 0 | 1 | 0 | 92,20 € | 99,50 € | 7,92 % |
| UCB S.A. | 2 | 0 | 0 | 0 | 124,30 € | - | - |
| Ipsen S.A. | 1 | 0 | 0 | 0 | 113,60 € | 109,00 € | -4,05 % |
| Novartis AG ADR | 1 | 0 | 0 | 0 | 91,00 € | - | - |
| AstraZeneca plc | 1 | 0 | 0 | 0 | 142,05 € | 165,00 € | 16,16 % |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | 118,65 € | 130,00 € | 9,57 % |
| GSK plc | 1 | 0 | 0 | 0 | 19,51 € | - | - |